<DOC>
	<DOCNO>NCT00004785</DOCNO>
	<brief_summary>OBJECTIVES : I . Compare efficacy dexamethasone ( DM ) vs. DM/methylprednisolone treatment vs. placebo , initiate within first month life , long-term pulmonary developmental outcome premature infant evolve bronchopulmonary dysplasia . II . Compare toxicities treatment . III . Assess treatment effect adrenal function .</brief_summary>
	<brief_title>Phase III Randomized , Double-Blind Study Dexamethasone Vs Dexamethasone/Methylprednisolone Vs Placebo Bronchopulmonary Dysplasia</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double-blind study . Patients randomly assign 1 3 treatment group . The first group receive intravenous dexamethasone taper 42 day . The second group receive daily intravenous dexamethasone 6 day , intravenous methylprednisolone ( MePRDL ) taper next 34 day , begin day 8 . A placebo give `` '' MePRDL day . The third group receive intravenous placebo 42 day , taper schedule begin day 35 . All patient may receive 6 day dexamethasone rescue therapy begin day 15 and/or 30 , clinically indicate . Study drug suspend rescue therapy .</detailed_description>
	<mesh_term>Bronchopulmonary Dysplasia</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Premature infants evolve bronchopulmonary dysplasia chest xray Requirement mechanical ventilation Fraction inspire oxygen great 0.30 Ventilator least 15 cycles/minute No sign wean within 72 hour prior entry No serious congenital anomaly Prior/Concurrent Therapy No prior postnatal corticosteroid Patient Characteristics Cardiovascular : No congenital heart disease Other : Birth weight great 1500 g Gestational age great 30 week No contraindication corticosteroid , e.g. , cultureproven bacterial sepsis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>2 Weeks</maximum_age>
	<verification_date>December 2001</verification_date>
	<keyword>bronchopulmonary dysplasia</keyword>
	<keyword>cardiovascular respiratory disease</keyword>
	<keyword>neonatal disorder</keyword>
	<keyword>rare disease</keyword>
</DOC>